Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - Revision v3.5.0 added to the Record History, and revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T16:51:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the Record History and crossed out Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T10:48:49.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added to the history log and Revision v3.4.1 was removed. These are site-wide updates and notices rather than changes to trial data or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T01:56:41.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added a government funding/status notice and the new site revision tag v3.4.1, and removed the previous revision tag v3.4.0.
    Difference
    0.9%
    Check dated 2026-02-03T23:39:43.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The Record History page adds a glossary, color-coded highlights for additions (green) and deletions (red), and a revision badge (v3.4.0).
    Difference
    1%
    Check dated 2026-01-27T21:11:01.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    New revision entry Revision: v3.3.3 was added to the page history. The footer now removes HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T02:17:16.000Z thumbnail image

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.